Tonix licenses global rights to novel non-opioid neuropathic pain drug TNX-4900
Proactive - Interviews for investors · Proactive Investors
December 24, 20254m 20s
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.